COVID-19 vaccine lot release to be authorized this week
By Lee, Tak-Sun | translator Byun Kyung A
21.02.10 14:46:56
가나다라
0
KDCA expected to provide guideline on the use for elderly group aged over 65
Additional clinical data targeting 30,000 Americans to be submitted by the end of April
▲Minister of Food and Drug Safety Kim Gang-lip is explaining about the final authorization on AstraZeneca COVID-19 vaccine on Feb. 10.
As a COVID-19 vaccine was authorized for the first time in South Korea, the lot release for AstraZeneca’s vaccine is expected to be granted this week. Although South Korea’s Ministry of Food and Drug Safety (MFDS) did not restrict inoculation on the age group over 65, the Korea Advisory Committee on Immunization Practices (KACIP) associated under Korea Disease Control and Prevention Agency (KDCA) is to make the final call. However, as a group of experts has decided the vaccine should also be accessible to population over 65, the advisory committee would be likely to follow the same direction.
At the AstraZeneca COVID-19 vaccine authorization briefing presented on Feb. 10, the Ministe
Lee, Tak-Sun(hooggasi2@dailypharm.com)
If you want to see the full article, please JOIN US (click)